List of Tables
Table 1. Global Pharmacokinetic Evaluation Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of In Vivo Pharmacokinetics
Table 3. Key Players of In Vitro Pharmacokinetics
Table 4. Global Pharmacokinetic Evaluation Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global Pharmacokinetic Evaluation Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Pharmacokinetic Evaluation Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global Pharmacokinetic Evaluation Market Share by Region (2020-2025)
Table 8. Global Pharmacokinetic Evaluation Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global Pharmacokinetic Evaluation Market Share by Region (2026-2031)
Table 10. Pharmacokinetic Evaluation Market Trends
Table 11. Pharmacokinetic Evaluation Market Drivers
Table 12. Pharmacokinetic Evaluation Market Challenges
Table 13. Pharmacokinetic Evaluation Market Restraints
Table 14. Global Pharmacokinetic Evaluation Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global Pharmacokinetic Evaluation Market Share by Players (2020-2025)
Table 16. Global Top Pharmacokinetic Evaluation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetic Evaluation as of 2024)
Table 17. Ranking of Global Top Pharmacokinetic Evaluation Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by Pharmacokinetic Evaluation Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of Pharmacokinetic Evaluation, Headquarters and Area Served
Table 20. Global Key Players of Pharmacokinetic Evaluation, Product and Application
Table 21. Global Key Players of Pharmacokinetic Evaluation, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmacokinetic Evaluation Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global Pharmacokinetic Evaluation Revenue Market Share by Type (2020-2025)
Table 25. Global Pharmacokinetic Evaluation Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global Pharmacokinetic Evaluation Revenue Market Share by Type (2026-2031)
Table 27. Global Pharmacokinetic Evaluation Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global Pharmacokinetic Evaluation Revenue Market Share by Application (2020-2025)
Table 29. Global Pharmacokinetic Evaluation Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global Pharmacokinetic Evaluation Revenue Market Share by Application (2026-2031)
Table 31. North America Pharmacokinetic Evaluation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America Pharmacokinetic Evaluation Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America Pharmacokinetic Evaluation Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe Pharmacokinetic Evaluation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe Pharmacokinetic Evaluation Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe Pharmacokinetic Evaluation Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific Pharmacokinetic Evaluation Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific Pharmacokinetic Evaluation Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific Pharmacokinetic Evaluation Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America Pharmacokinetic Evaluation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America Pharmacokinetic Evaluation Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America Pharmacokinetic Evaluation Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa Pharmacokinetic Evaluation Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa Pharmacokinetic Evaluation Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa Pharmacokinetic Evaluation Market Size by Country (2026-2031) & (US$ Million)
Table 46. PPD Company Details
Table 47. PPD Business Overview
Table 48. PPD Pharmacokinetic Evaluation Product
Table 49. PPD Revenue in Pharmacokinetic Evaluation Business (2020-2025) & (US$ Million)
Table 50. PPD Recent Development
Table 51. ICON（PRA） Company Details
Table 52. ICON（PRA） Business Overview
Table 53. ICON（PRA） Pharmacokinetic Evaluation Product
Table 54. ICON（PRA） Revenue in Pharmacokinetic Evaluation Business (2020-2025) & (US$ Million)
Table 55. ICON（PRA） Recent Development
Table 56. Charles River Company Details
Table 57. Charles River Business Overview
Table 58. Charles River Pharmacokinetic Evaluation Product
Table 59. Charles River Revenue in Pharmacokinetic Evaluation Business (2020-2025) & (US$ Million)
Table 60. Charles River Recent Development
Table 61. LabCorp Company Details
Table 62. LabCorp Business Overview
Table 63. LabCorp Pharmacokinetic Evaluation Product
Table 64. LabCorp Revenue in Pharmacokinetic Evaluation Business (2020-2025) & (US$ Million)
Table 65. LabCorp Recent Development
Table 66. IQVIA Company Details
Table 67. IQVIA Business Overview
Table 68. IQVIA Pharmacokinetic Evaluation Product
Table 69. IQVIA Revenue in Pharmacokinetic Evaluation Business (2020-2025) & (US$ Million)
Table 70. IQVIA Recent Development
Table 71. Crown Bioscience Company Details
Table 72. Crown Bioscience Business Overview
Table 73. Crown Bioscience Pharmacokinetic Evaluation Product
Table 74. Crown Bioscience Revenue in Pharmacokinetic Evaluation Business (2020-2025) & (US$ Million)
Table 75. Crown Bioscience Recent Development
Table 76. Shanghai Model Organisms Center Company Details
Table 77. Shanghai Model Organisms Center Business Overview
Table 78. Shanghai Model Organisms Center Pharmacokinetic Evaluation Product
Table 79. Shanghai Model Organisms Center Revenue in Pharmacokinetic Evaluation Business (2020-2025) & (US$ Million)
Table 80. Shanghai Model Organisms Center Recent Development
Table 81. Joinn Laboratories Company Details
Table 82. Joinn Laboratories Business Overview
Table 83. Joinn Laboratories Pharmacokinetic Evaluation Product
Table 84. Joinn Laboratories Revenue in Pharmacokinetic Evaluation Business (2020-2025) & (US$ Million)
Table 85. Joinn Laboratories Recent Development
Table 86. Shanghai Medicilon Company Details
Table 87. Shanghai Medicilon Business Overview
Table 88. Shanghai Medicilon Pharmacokinetic Evaluation Product
Table 89. Shanghai Medicilon Revenue in Pharmacokinetic Evaluation Business (2020-2025) & (US$ Million)
Table 90. Shanghai Medicilon Recent Development
Table 91. PharmaLegacy Laboratories Company Details
Table 92. PharmaLegacy Laboratories Business Overview
Table 93. PharmaLegacy Laboratories Pharmacokinetic Evaluation Product
Table 94. PharmaLegacy Laboratories Revenue in Pharmacokinetic Evaluation Business (2020-2025) & (US$ Million)
Table 95. PharmaLegacy Laboratories Recent Development
Table 96. WuXi AppTec Company Details
Table 97. WuXi AppTec Business Overview
Table 98. WuXi AppTec Pharmacokinetic Evaluation Product
Table 99. WuXi AppTec Revenue in Pharmacokinetic Evaluation Business (2020-2025) & (US$ Million)
Table 100. WuXi AppTec Recent Development
Table 101. Pharmaron Company Details
Table 102. Pharmaron Business Overview
Table 103. Pharmaron Pharmacokinetic Evaluation Product
Table 104. Pharmaron Revenue in Pharmacokinetic Evaluation Business (2020-2025) & (US$ Million)
Table 105. Pharmaron Recent Development
Table 106. ChemPartner PharmaTech Company Details
Table 107. ChemPartner PharmaTech Business Overview
Table 108. ChemPartner PharmaTech Pharmacokinetic Evaluation Product
Table 109. ChemPartner PharmaTech Revenue in Pharmacokinetic Evaluation Business (2020-2025) & (US$ Million)
Table 110. ChemPartner PharmaTech Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report
List of Figures
Figure 1. Pharmacokinetic Evaluation Picture
Figure 2. Global Pharmacokinetic Evaluation Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Pharmacokinetic Evaluation Market Share by Type: 2024 VS 2031
Figure 4. In Vivo Pharmacokinetics Features
Figure 5. In Vitro Pharmacokinetics Features
Figure 6. Global Pharmacokinetic Evaluation Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global Pharmacokinetic Evaluation Market Share by Application: 2024 VS 2031
Figure 8. Drug Development Company Case Studies
Figure 9. CRO Enterprise Case Studies
Figure 10. Scientific Research Unit Case Studies
Figure 11. Pharmacokinetic Evaluation Report Years Considered
Figure 12. Global Pharmacokinetic Evaluation Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Pharmacokinetic Evaluation Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Pharmacokinetic Evaluation Market Share by Region: 2024 VS 2031
Figure 15. Global Pharmacokinetic Evaluation Market Share by Players in 2024
Figure 16. Global Top Pharmacokinetic Evaluation Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmacokinetic Evaluation as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Pharmacokinetic Evaluation Revenue in 2024
Figure 18. North America Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Pharmacokinetic Evaluation Market Share by Country (2020-2031)
Figure 20. United States Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Pharmacokinetic Evaluation Market Share by Country (2020-2031)
Figure 24. Germany Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Pharmacokinetic Evaluation Market Share by Region (2020-2031)
Figure 32. China Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Pharmacokinetic Evaluation Market Share by Country (2020-2031)
Figure 40. Mexico Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Pharmacokinetic Evaluation Market Share by Country (2020-2031)
Figure 44. Turkey Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Pharmacokinetic Evaluation Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. PPD Revenue Growth Rate in Pharmacokinetic Evaluation Business (2020-2025)
Figure 48. ICON（PRA） Revenue Growth Rate in Pharmacokinetic Evaluation Business (2020-2025)
Figure 49. Charles River Revenue Growth Rate in Pharmacokinetic Evaluation Business (2020-2025)
Figure 50. LabCorp Revenue Growth Rate in Pharmacokinetic Evaluation Business (2020-2025)
Figure 51. IQVIA Revenue Growth Rate in Pharmacokinetic Evaluation Business (2020-2025)
Figure 52. Crown Bioscience Revenue Growth Rate in Pharmacokinetic Evaluation Business (2020-2025)
Figure 53. Shanghai Model Organisms Center Revenue Growth Rate in Pharmacokinetic Evaluation Business (2020-2025)
Figure 54. Joinn Laboratories Revenue Growth Rate in Pharmacokinetic Evaluation Business (2020-2025)
Figure 55. Shanghai Medicilon Revenue Growth Rate in Pharmacokinetic Evaluation Business (2020-2025)
Figure 56. PharmaLegacy Laboratories Revenue Growth Rate in Pharmacokinetic Evaluation Business (2020-2025)
Figure 57. WuXi AppTec Revenue Growth Rate in Pharmacokinetic Evaluation Business (2020-2025)
Figure 58. Pharmaron Revenue Growth Rate in Pharmacokinetic Evaluation Business (2020-2025)
Figure 59. ChemPartner PharmaTech Revenue Growth Rate in Pharmacokinetic Evaluation Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
